Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-70345

Single-particle
28.0 Å
EMD-70345 Deposition: 25/04/2025
Map released: 27/08/2025
Last modified: 27/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-70345

BG505 MD39.3-CC5 SOSIP in complex with C3V5 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization

EMD-70345

Single-particle
28.0 Å
EMD-70345 Deposition: 25/04/2025
Map released: 27/08/2025
Last modified: 27/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1
Sample: BG505 MD39.3-CC5 SOSIP in complex with C3V5 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization

Deposition Authors: Lee W-H , Ozorowski G , Ward AB
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.
PUBMED: 40737434
DOI: doi:10.1126/scitranslmed.ady6831
ISSN: 1946-6242